Recent studies have shown that CEACAM19 is upregulated, at the mRNA level, in ovarian and breast cancer.
| Inventor | Institute |
|---|---|
| Ayham Alnabulsi | Vertebrate Antibodies Limited |
| Cat. #: | 153245 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Cancer types: | Digestive / Gastrointestinal cancer |
| Research Fields: | Apoptosis and autophagy;Cancer;Cell biology |
| Application: | ELISA ; WB |
| Target: | Carcinoembryonic Antigen Related Cell Adhesion Molecule 19 |
| Reactivity: | Human |
| Clone: | Z5P2D9*A9 |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | CEACAM19, CEA related cell adhesion molecule 19, CEAL1 |
|---|---|
| Product description: | CEACAM19 belongs to the carcinoembryonic antigen (CEA) gene family. In humans, this family of proteins are involved in several key biological processes such as cell adhesion, cell growth and differentiation, cellular recognition, apoptosis and angiogenesis. Recent studies have shown that CEACAM19 is upregulated, at the mRNA level, in ovarian and breast cancer. |
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Immunogen: | Peptide sequence RSINPARPLP (BLAST analysis revealed 100% identity with Gorilla) |
| Myeloma used: | P3X63Ag8.653 |
| Target background: | CEACAM19 belongs to the carcinoembryonic antigen (CEA) gene family. In humans, this family of proteins are involved in several key biological processes such as cell adhesion, cell growth and differentiation, cellular recognition, apoptosis and angiogenesis. Recent studies have shown that CEACAM19 is upregulated, at the mRNA level, in ovarian and breast cancer. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.